Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer's disease

Movement Disorders

Volumn 21, Issue 3, 2006, Pages 337-342

  Janvin, Carmen Cristea ^a   Larsen, Jan Petter ^a   Salmon, David P ^b   Galasko, Douglas ^b   Hugdahl, Kenneth ^c   Aarsland, Dag ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cortical subcortical cognitive profile; Dementia; Parkinson's disease

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX LESION; CLINICAL EXAMINATION; CLUSTER ANALYSIS; COGNITION; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; DATA ANALYSIS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; INDIVIDUALITY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NORWAY; PARKINSON DISEASE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARDIZATION; UNITED STATES;

AGED; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 33645552854     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20726     Document Type: Article

References (29)

1. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997;244:2-8.
2. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1215-1220.
3. Galasko D, Salmon DP. The Alzheimer-Parkinson's disease connection. In: Clark CM, Trojanowski JQ, editors. Neurodegenerative dementias: clinical features and pathological mechanisms. New York: McGraw-Hill; 2000. p 235.
4. Jellinger KA. Neuropathological correlates of mental dysfunction in Parkinson's disease. In: Wolters EC, Scheltenes P, Berendse HW, editors. Mental dysfunction in Parkinson's disease II. Utrecht: APA; 1999. p 82-105.
5. Foltynie T, Brayne C, Barker RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol 2002;249:138-145.
6. Mattis S. Dementia Rating Scale. In: Bellak L, Karasu TB, editors. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians. New York: Grune & Stratton; 1976. p 108-121.
7. Brown GG, Rahill AA, Gorell JM, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999;12:180-188.
8. Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995;10:541-549.
9. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;89:242-251.
10. Diagnostic and statistical manual of mental disorders (3rd ed., revised) DSM-III-R. Washington, DC: American Psychiatric Association; 1987. 567 p.
11. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
12. Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004;61:1906-1911.
13. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997;48:126-132.
14. World Health Organization. International classification of diseases. 10th ed. Geneva: World Health Organization; 1992; p 47-49.
15. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667-1674.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Salmon DP, Kwo-on-Yuen PF, Heindel WC, Butters N, Thai I.J. Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol 1989;46:1204-1208.
18. Paulsen JS, Butters N, Sadek JR, et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology 1995;45:951-956.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
20. Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
21. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
22. Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 2002;109:329-339.
23. Bruck A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 2004;75:1467-1469.
24. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102-112.
25. Mattila PM, Roytta M, Lonnberg P, Marjamaki P, Helenius H, Rinne JO. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol (Berl) 2001;102:160-166:
26. Tiraboschi P, Hansen LA, Alford M, et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000;54:407-411.
27. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125:391-403.
28. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59: 1714-1720.
29. Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol 1995;52:899-904.